findmyKOL
Clinical trialNCT05162482UnknownPhase 2Interventional

Combination Assessment Trial of COVID-19 Vaccines (COMBAT-COVID)

SponsorAga Khan University Hospital, PakistanEnrollment1,680COVID 19 Vaccine
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Pakistan
  • National Institute of Health

    Islamabad, Punjab Province, Pakistan

  • Chughtai Lab

    Lahore, Punjab Province, Pakistan

  • Aga Khan University

    Karachi, Sindh, Pakistan

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Mar 2022
Primary completion
30 Jun 2024
Completion
30 Jun 2024
Last update posted
18 Feb 2022
Registered enrollment
1,680
Registry id
NCT05162482
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.